Compile Data Set for Download or QSAR
Report error Found 48 Enz. Inhib. hit(s) with all data for entry = 10016
TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508496(5-chloro-N-[(9S,9aS)-9-hydroxy-5-oxo-8,9,9a,10-tet...)
Affinity DataIC50: 0.400nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508497(5-chloro-N-[(9S,9aS)-9-hydroxy-5-oxo-8,9,9a,10-tet...)
Affinity DataIC50: 0.400nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508503(methyl [(8R,9aR)-3-{[(5-chloro-2-methoxyphenyl)sul...)
Affinity DataIC50: 0.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508500(5-chloro-2-methoxy-N-[(8S,9aR)-8-methoxy-5-oxo-8,9...)
Affinity DataIC50: 0.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508512(2-ethoxy-5-fluoro-N-[(10aS)-7-oxo-7,8,10a,11-tetra...)
Affinity DataIC50: 0.600nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508502((8S,9aR)-3-{[(5-chloro-2-methoxyphenyl)sulfonyl]am...)
Affinity DataIC50: 0.600nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508498(5-chloro-N-[(8S,9aR)-8-fluoro-5-oxo-8,9,9a,10-tetr...)
Affinity DataIC50: 0.800nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508487(US11046710, Example 30)
Affinity DataIC50: 0.900nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508489(US11046710, Example 32)
Affinity DataIC50: 0.900nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508491(US11046710, Example 35)
Affinity DataIC50: 0.900nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508506(US11046710, Example 54)
Affinity DataIC50: 1.10nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508488(US11046710, Example 31)
Affinity DataIC50: 1.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508485(US11046710, Example 28)
Affinity DataIC50: 1.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508507(5-chloro-N-[(8S,9aS)-8-hydroxy-7-oxo-8,9,9a,10-tet...)
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508493(US11046710, Example 37)
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508510(5-chloro-2-methoxy-N-[(10aS)-7-oxo-7,8,9,10,10a, 1...)
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508513(US11046710, Example 63)
Affinity DataIC50: 1.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508501((8S,9aR)-3-({[5-chloro-2-(trifluoromethoxy)phenyl]...)
Affinity DataIC50: 1.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508492(US11046710, Example 36)
Affinity DataIC50: 1.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508490(US11046710, Example 34)
Affinity DataIC50: 1.60nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508514(5-chloro-2-methoxy-N-[(10aS)-9-methyl-7-oxo-7,8,9,...)
Affinity DataIC50: 1.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508499(5-chloro-N-[(9aR)-8,8-difluoro-5-oxo-8,9,9a,10-tet...)
Affinity DataIC50: 2nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508504(5-chloro-2-methoxy-N-[(9aS)-7-oxo-8,9,9a,10-tetrah...)
Affinity DataIC50: 2.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508482(US11046710, Example 24)
Affinity DataIC50: 2.30nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508467(US11046710, Example 3)
Affinity DataIC50: 2.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508494(5-fluoro-N-[(8R,9aR)-8-hydroxy-5-oxo-8,9,9a,10-tet...)
Affinity DataIC50: 2.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508466(US11046710, Example 1)
Affinity DataIC50: 2.60nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508468(US11046710, Example 5)
Affinity DataIC50: 2.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508478(US11046710, Example 18)
Affinity DataIC50: 2.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508480(US11046710, Example 21)
Affinity DataIC50: 3nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508511(US11046710, Example 60)
Affinity DataIC50: 3.30nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508471(US11046710, Example 9)
Affinity DataIC50: 3.40nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508476(US11046710, Example 16)
Affinity DataIC50: 3.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508475(US11046710, Example 14)
Affinity DataIC50: 3.60nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508508(5-chloro-2-methoxy-N-[(9aR)-7-oxo-9a,10-dihydro-5H...)
Affinity DataIC50: 3.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508479(US11046710, Example 20)
Affinity DataIC50: 4.20nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508505(5-chloro-N-[(8R,9aS)-8-hydroxy-7-oxo-8,9,9a,10-tet...)
Affinity DataIC50: 4.30nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508474(US11046710, Example 13)
Affinity DataIC50: 5.10nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508481(US11046710, Example 23)
Affinity DataIC50: 5.70nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508495(5-chloro-N-[(9R,9aS)-9-hydroxy-5-oxo-8,9,9a,10-tet...)
Affinity DataIC50: 5.80nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508469(US11046710, Example 6)
Affinity DataIC50: 5.90nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508470(US11046710, Example 7)
Affinity DataIC50: 6.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508477(US11046710, Example 17)
Affinity DataIC50: 6.90nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508486(US11046710, Example 29)
Affinity DataIC50: 7.10nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508473(US11046710, Example 12)
Affinity DataIC50: 8.5nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508472(US11046710, Example 11)
Affinity DataIC50: 12.6nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508484(US11046710, Example 27)
Affinity DataIC50: 13.2nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent

TargetAlkaline phosphatase, tissue-nonspecific isozyme(Human)
Daiichi Sankyo

US Patent
LigandPNGBDBM508483(US11046710, Example 26)
Affinity DataIC50: 29.4nMAssay Description:COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2021
Entry Details
Go to US Patent